Genprex (GNPX) Cash & Equivalents (2016 - 2026)
Genprex (GNPX) reported Cash & Equivalents of $15.15 million for Q2 2026, compared with $1.35 million a year earlier and down 16.0% from the prior quarter.
Powered by 
Analysis
Genprex (GNPX) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Genprex posted Cash & Equivalents of $7.83 million, up 388.9% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $1.6 million in FY2024 (-76.2%), $6.74 million in FY2023 (-67.8%), $20.95 million in FY2022 (-45.8%) and $38.63 million in FY2021 (+41.4%).
- Five-year quarterly Cash & Equivalents spans a low of $1.1 million in Q3 2025 and a high of $42.02 million in Q3 2021.
- Year over year, Cash & Equivalents gained in two of the last seven quarters, with growth averaging 73.8%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2026 (growth of 420.4%); the low point was Q3 2024 (a decline of 87.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $18.05 million (Q1 2026), $7.83 million (Q4 2025) and $1.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Genprex | 1.30 Mn | -40.84 Mn | - | 15.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.15 Mn |
| Mar 31, 2026 | 18.05 Mn |
| Dec 31, 2025 | 7.83 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 8.22 Mn |
| Dec 31, 2023 | 6.74 Mn |
| Sep 30, 2023 | 11.71 Mn |
| Jun 30, 2023 | 9.96 Mn |
| Mar 31, 2023 | 18.08 Mn |
| Dec 31, 2022 | 20.95 Mn |
| Sep 30, 2022 | 25.52 Mn |
| Jun 30, 2022 | 30.05 Mn |
| Mar 31, 2022 | 34.56 Mn |
| Dec 31, 2021 | 38.63 Mn |
| Sep 30, 2021 | 42.02 Mn |
API Access
Genprex Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GNPX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GNPX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GNPX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();